In addition to visualizing the microcirculation by labelling the endothelium or by labelling circulating cells within the vessels, injection of a vascular contrast agent such as a fluorophore-conjugated protein (e.g., FITC-albumin) immediately and clearly defines the structure of the tumor vasculature (Figure 4d) and provides information regarding tissue perfusion. The gene discussed is ALB; the disease is neoplasm.